Transient and sustained ERK phosphorylation and nuclear translocation in growth control

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Cellular Physiology

• Publication date

  2002-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jcp.10124PMID 12115721
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein Kinases and Phosphatases: The Yin and Yang of Protein Phosphorylation and Signaling Review

  2004cited by this paper
• EGFR‐independent activation of ERK1/2 mediates growth inhibition by a PTPase antagonizing K‐vitamin analog

  2002cited by this paper
• Induction of apoptosis via mitogen-activated protein kinase pathway by a K vitamin analog in rat hepatocytes.

  2002cited by this paper
• Spatial Analysis of Key Signaling Proteins by High-content Solid-phase Cytometry in Hep3B Cells Treated with an Inhibitor of Cdc25 Dual-specificity Phosphatases*

  2001cited by this paper
• Cdc25 inhibition and cell cycle arrest by a synthetic thioalkyl vitamin K analogue.

  2000cited by this paper
• Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen‐activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin

  2000cited by this paper
• Expression of immediate early gene pip92 during anisomycin-induced cell death is mediated by the JNK- and p38-dependent activation of Elk1.

  2000cited by this paper
• Signal transduction: A central control for cell growth

  2000cited by this paper
• Inhibition of Hepatoma Cell Growth in Vitro by Arylating and Non-arylating K Vitamin Analogs

  1999cited by this paper
• Organization and regulation of mitogen-activated protein kinase signaling pathways.

  1999cited by this paper
• Destruction of Myc by ubiquitin‐mediated proteolysis: cancer‐associated and transforming mutations stabilize Myc

  1999cited by this paper
• Signaling by dual specificity kinases

  1998cited by this paper
• Epidermal growth factor-induced growth inhibition requires Stat1 activation.

  1998cited by this paper
• Induction of the mitogen‐activated protein kinase phosphatase MKP3 by nerve growth factor in differentiating PC12

  1998cited by this paper
• Nuclear translocation of mitogen-activated protein kinase kinase (MEK1) in response to mitogenic stimulation.

  1997cited by this paper
• MKP-3, a Novel Cytosolic Protein-tyrosine Phosphatase That Exemplifies a New Class of Mitogen-activated Protein Kinase Phosphatase (*)

  1996cited by this paper
• Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways

  1996cited by this paper
• Cytoplasmic Localization of Mitogen-activated Protein Kinase Kinase Directed by Its NH2-terminal, Leucine-rich Short Amino Acid Sequence, Which Acts as a Nuclear Export Signal*

  1996cited by this paper
• Construction of a Human Genomic Library of Clones Containing Poly(dG-dA)Poly(dT-dC) Tracts by Mg-dependent Triplex Affinity Capture

  1995influential reference
• Thioalkyl Derivatives of Vitamin K3 and Vitamin K3 Oxide Inhibit Growth of Hep3B and HepG2 Cells

  1995cited by this paper
• Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

  1995cited by this paper
• Growth Inhibition of Hepatoma Cells Induced by Vitamin K and Its Analogs (*)

  1995cited by this paper
• The epidermal growth factor.

  1995cited by this paper
• Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling.

  1995cited by this paper
• Multiple Dual Specificity Protein Tyrosine Phosphatases Are Expressed and Regulated Differentially in Liver Cell Lines (*)

  1995cited by this paper
• The growth inhibitory effects of vitamins K and their actions on gene expression

  1995cited by this paper
• A Novel Mitogen-activated Protein Kinase Phosphatase. STRUCTURE, EXPRESSION, AND REGULATION (*)

  1995cited by this paper
• Vitamin K3-induced cell cycle arrest and apoptotic cell death are accompanied by altered expression of c-fos and c-myc in nasopharyngeal carcinoma cells.

  1993cited by this paper
• MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo.

  1993cited by this paper
• cPLA2 is phosphorylated and activated by MAP kinase.

  1993influential reference
• cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein.

  1992cited by this paper
• Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor.

  1992cited by this paper
• Nuclear localization and regulation of erk- and rsk-encoded protein kinases

  1992cited by this paper
• DNA strand scission and free radical production in menadione-treated cells. Correlation with cytotoxicity and role of NADPH quinone acceptor oxidoreductase.

  1992cited by this paper
• Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor.

  1992cited by this paper
• Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase.

  1991cited by this paper
• The toxicity of menadione (2-methyl-1,4-naphthoquinone) and two thioether conjugates studied with isolated renal epithelial cells.

  1991cited by this paper
• Menadione-induced DNA damage in a human tumor cell line.

  1991influential reference
• DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water.

  1990cited by this paper
• Effects of sodium ascorbate (vitamin C) and 2‐methyl‐1,4‐naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action

  1989cited by this paper
• Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

  1989cited by this paper
• Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II

  1988cited by this paper
• Redox cycling and sulphydryl arylation; their relative importance in the mechanism of quinone cytotoxicity to isolated hepatocytes.

  1988cited by this paper
• Reactivity of thiols towards derivatives of 2- and 6-methyl-1,4-naphthoquinone bioreductive alkylating agents.

  1987cited by this paper
• Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation.

  1985cited by this paper
• Vitamin K3 (menadione) inhibits the growth of mammalian tumor cells in culture.

  1981cited by this paper
• Epidermal growth factor

  1972cited by this paper

• Fusobacterium nucleatum produces previously unappreciated AHR-activating metabolites and promotes CRC cell proliferation via the AHR-TERT axis

  2025cites this paper
• EGFL6 is a novel HER3 ligand, inducing HER3/integrin heterodimers to induce pERK centrosomal deposition and therapeutic resistance

  2025cites this paper
• Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review

  2025cites this paper
• Interdependency and differential expression of ERK1 and ERK2 in breast and melanoma cell lines

  2024cites this paper
• Low Levels of Nicotine and Cotinine but not Benzo[a]Pyrene Induce Human Trophoblast Cell Proliferation.

  2024cites this paper
• Comparative study of the molecular mechanisms underlying the G protein and β‐arrestin‐dependent pathways that lead to ERKs activation upon stimulation by dopamine D2 receptor

  2023cites this paper
• Arsenic compounds activate MAPK and inhibit Akt pathways to induce apoptosis in MA‐10 mouse Leydig tumor cells

  2022cites this paper
• The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro

  2021cites this paper
• Role of Reactive Oxygen Species in the Cytotoxicity of Arsenic Trioxide and Pamidronate for Human Prostate Cancer Cells.

  2020cites this paper
• MAPK SIGNALLING PATHWAY: ROLE IN CANCER PATHOGENESIS

  2019cites this paper
• 7,8-Dihydroxyflavone Protects Nigrostriatal Dopaminergic Neurons from Rotenone-Induced Neurotoxicity in Rodents

  2019cites this paper
• Amino acids as signaling molecules modulating bone turnover.

  2018cites this paper
• Inhibitory effect of estrogen receptor beta on P2X3 receptors during inflammation in rats

  2016cites this paper
• Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer

  2016cites this paper
• Quantitative Analysis of Receptor Tyrosine Kinase-Effector Coupling at Functionally Relevant Stimulus Levels*♦

  2015cites this paper
• Regulation of ERK-MAPK signaling in human epidermis

  2015cites this paper
• GATA2 promotes glioma progression through EGFR/ERK/Elk-1 pathway

  2015cites this paper
• Microsoft Word-Li et al (Revised) 1-21-15.docx

  2015cites this paper
• Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticles

  2015cites this paper
• Molecular Mechanisms Underlying the Muscle Response to Exercise-Induced Muscle Damage in Chronic Cigarette Smokers

  2015cites this paper
• Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells.

  2014cites this paper
• GPER Signaling in Spermatogenesis and Testicular Tumors

  2014cites this paper
• Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells

  2013cites this paper
• The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer

  2013cites this paper
• Sulforaphane (SFN) regulates dedifferentiation and cyclooxygenase-2 (COX-2) expression via MAPkinase pathway in rabbit articular chondrocytes

  2013cites this paper
• Pathways in Human Neutrophils Signaling Factor Activation through Separate RIIIB Mediate Nuclear γ RIIA and Fc γ Fc

  2013cites this paper
• Targeting MAPK pathway in melanoma therapy

  2013cites this paper
• Role of Rho GTPases in Human Trophoblast Migration Induced by IGFBP11

  2012cites this paper
• Molecular-Targeted Therapy for Melanoma

  2012cites this paper
• 17β-Estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocyte-derived cell line.

  2012cites this paper
• Icaritin Causes Sustained ERK1/2 Activation and Induces Apoptosis in Human Endometrial Cancer Cells

  2011cites this paper
• An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells.

  2011cites this paper
• Signaling during Mechanical Strain Injury of the Urinary Bladder: ERK, STAT3 and mTOR Pathways

  2011cites this paper
• Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.

  2010cites this paper
• Activation of GPR30 inhibits growth of prostate cancer cells via sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G2 cell-cycle arrest

  2010cites this paper
• Epileptiform discharge upregulates p-ERK1/2, growth-associated protein 43 and synaptophysin in cultured rat hippocampal neurons.

  2009cites this paper
• Activation of MEK 1/2 and p42/44 MAPK by angiotensin II in hepatocyte nucleus and their potentiation by ethanol.

  2009cites this paper
• This information is current as Pathways in Human Neutrophils SignalingFactor Activation through Separate RIIIB Mediate Nuclear γ RIIA and Fc γ

  2009cites this paper
• Melanoma: molecular pathogenesis and emerging target therapies (Review).

  2009cites this paper
• Investigating Differential Dynamics of the MAPK Signaling Cascade Using a Multi-Parametric Global Sensitivity Analysis

  2009cites this paper
• FcγRIIA and FcγRIIIB Mediate Nuclear Factor Activation through Separate Signaling Pathways in Human Neutrophils 1

  2009cites this paper
• Down-regulation of c-Cbl by Morphine Accounts for Persistent ERK1/2 Signaling in δ-Opioid Receptor-expressing HEK293 Cells

  2009cites this paper
• Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy.

  2008cites this paper
• Cdc25A protein phosphatase: a therapeutic target for liver cancer therapies.

  2008cites this paper
• Combining chemo-, hormonal and targeted therapies to treat breast cancer (Review).

  2008cites this paper
• Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with β1 integrins

  2008cites this paper
• Targeting the Raf/MEK/ERK pathway with small-molecule inhibitors.

  2008cites this paper
• Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia

  2008cites this paper
• Akt as a therapeutic target in cancer

  2008cites this paper
• An analysis of nerve growth factor-dependent differentiation and neurite outgrowth in the PC12 cell model system

  2008cites this paper
• Targeting Survival Cascades Induced by Activation of Ras/Raf/MEK/ERK and PI3K/Akt Pathways to Sensitize Cancer Cells to Therapy

  2008cites this paper
• Nuclear factor activation by FcgammaR in human peripheral blood neutrophils detected by a novel flow cytometry-based method.

  2007cites this paper
• Late endosomal traffic of the epidermal growth factor receptor ensures spatial and temporal fidelity of mitogen-activated protein kinase signaling.

  2007cites this paper
• P2Y nucleotide receptor signaling through MAPK/ERK is regulated by extracellular matrix: Involvement of β3 integrins

  2007cites this paper
• Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance.

  2007cites this paper
• Late endosomal traffic of the EGFR ensures spatial and temporal fidelity of MAPK signaling

  2007cites this paper
• Endosulfan decreases cell growth and apoptosis in human HaCaT keratinocytes: Partial ROS‐dependent ERK1/2 mechanism

  2007cites this paper
• Sustained activation of extracellular signal‐regulated kinase by nerve growth factor regulates c‐fos protein stabilization and transactivation in PC12 cells

  2006cites this paper
• Identification of Transcriptional Regulators Using Binding Site Enrichment Analysis

  2006cites this paper
• Phosphorylation regulates Myc expression via prolonged activation of the mitogen‐activated protein kinase pathway

  2006cites this paper
• Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK.

  2006cites this paper
• Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition.

  2006cites this paper
• JAK2 AND SRC FAMILY TYROSINE KINASE SIGNALING VIA THE ANGIOTENSIN II TYPE 1 RECEPTOR

  2006cites this paper
• H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERK

  2006cites this paper
• Laminin 5 Regulates Polycystic Kidney Cell Proliferation and Cyst Formation*

  2006cites this paper
• Srcasm Modulates EGF and Src-kinase Signaling in Keratinocytes*

  2005cites this paper
• Novel hydroxyl naphthoquinones with potent Cdc25 antagonizing and growth inhibitory properties

  2005cites this paper
• Farnesyl transferase inhibitor (R115777)-induced inhibition of STAT3(Tyr705) phosphorylation in human pancreatic cancer cell lines require extracellular signal-regulated kinases.

  2005cites this paper
• Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis.

  2005cites this paper
• Hepatocyte growth factor enhances protein phosphatase Cdc25A inhibitor compound 5‐induced hepatoma cell growth inhibition via Akt‐mediated MAPK pathway

  2005cites this paper
• Chemoprevention of prostate cancer with selenium: An update on current clinical trials and preclinical findings

  2004cites this paper
• Jak2 Tyrosine Kinase Mediates Angiotensin II-dependent Inactivation of ERK2 via Induction of Mitogen-activated Protein Kinase Phosphatase 1*

  2004cites this paper
• Involvement of c-Myc in growth inhibition of Hep 3B human hepatoma cells by a vitamin K analog.

  2004cites this paper
• Inhibition of rat liver regeneration after partial hepatectomy and induction of ERK phosphorylation by Cpd 5, a K vitamin-based anticancer compound.

  2004cites this paper
• Phosphorylation Regulates KSR1 Stability, ERK Activation, and Cell Proliferation*

  2004cites this paper
• FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells.

  2004cites this paper
• Jak2 TYROSINE KINASE: NEW INSIGHTS REGARDING STRUCTURE, FUNCTION, AND PHARMACOLOGY

  2004cites this paper
• Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains

  2003cites this paper
• Roles of Src and Epidermal Growth Factor Receptor Transactivation in Transient and Sustained ERK1/2 Responses to Gonadotropin-releasing Hormone Receptor Activation*

  2003cites this paper
• JS‐K, a novel non‐ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c‐Jun phosphorylation via multiple MAP kinase pathways

  2003cites this paper
• Persistent ERK Phosphorylation Negatively Regulates cAMP Response Element-binding Protein (CREB) Activity via Recruitment of CREB-binding Protein to pp90RSK *

  2003cites this paper
• K vitamins, PTP antagonism, and cell growth arrest

  2002cites this paper
• Activation of Gpr30 Inhibits Growth of Prostate Cancer Cells via Sustained Activation of Erk1/2, C-jun/c-fos-dependent Upregulation of P21, and Induction of G2 Cell-cycle Arrest Hhs Public Access Introduction

  year unknowncites this paper